BackBiostar Pharmaceuticals Overview

Biostar Pharmaceuticals Selling, General & Admin

Selling, General & Admin expenses for BSPM.

Quarterly SG&A Expenses

$573381.00
↓ 26.4% YoY

As of Sep 30, 2017

Annual SG&A Expenses (TTM)

$4.12M
↓ 16.82% YoY

Trailing 12 months ending Sep 30, 2017

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin